Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Adults Chronically Infected With Genotype 2 Hepatitis C Virus: an Open-label, Multicenter Confirmatory Study

NCT03453346 is registered in ClinicalTrials.gov with Kawin Technology Share-holding Co., Ltd. as lead sponsor.

NCT NCT03453346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03453346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Adults Chronically Infected With Genotype 2 Hepatitis C Virus: an Open-label, Multicenter Confirmatory Study
Lead sponsor
Kawin Technology Share-holding Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
August 5, 2016
Completion date
March 30, 2017
Enrollment
136 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus infection, response to therapy of, hepatitis c, chronic